Clinical trial
SELECT: cardiovascular outcomes in a specific high-risk population
SELECT studied cardiovascular events, rather than weight change alone.
Read the study note ↗THE RESEARCH LIBRARY
Read the research.
Keep the context.
190 source-linked study notes. Explore the design, findings and limits behind the headline.
190 study notes Page 9 of 16
Clinical trial
STEP-HFpEF: symptoms and function in obesity-related heart failure
This study focused on symptoms, physical limitations and body weight in a defined heart-failure population.
Read the study note ↗Clinical trial
SURMOUNT-3: a study after successful lifestyle intervention
Who entered the randomized phase is central to interpreting this study.
Read the study note ↗Follow-up study
After STEP 1: what happened following withdrawal?
The extension study highlights why an end-of-treatment result is not a permanent-outcome guarantee.
Read the study note ↗Clinical trial
Glutathione in diabetes: overall findings and post hoc age subgroups
An oral-supplementation study followed diabetic participants receiving background treatment and measured redox and glycemic biomarkers over six months.
Read the study note ↗Clinical trial
Glutathione with cystine: interpreting a combination pigmentation trial
A blinded twelve-week trial in Asian women compared a defined oral combination, individual ingredients and placebo using instrumental skin measurements.
Read the study note ↗Preclinical study
Selank in a withdrawal model: a narrow preclinical question
A rat model used experimentally precipitated morphine withdrawal to compare selected behavioral signs after intervention.
Read the study note ↗Analytical study
Signature peptides: digestion efficiency and degradation both matter
Time-course proteomics compared peptide formation and stability when measuring human hepatic transporters and membrane markers.
Read the study note ↗Clinical trial
STEP 5: what two years of follow-up adds
Longer follow-up examines maintenance during ongoing treatment, rather than permanence after stopping.
Read the study note ↗Clinical trial
STEP 8: semaglutide versus liraglutide in an active-comparator trial
The head-to-head comparison adds information that separate placebo trials cannot provide.
Read the study note ↗Clinical trial
STEP TEENS: population and BMI endpoints matter in adolescent research
The trial investigated adolescents under monitored clinical conditions, not adult research-vial use.
Read the study note ↗Clinical trial
SURMOUNT-1: interpreting the first obesity trial
A large randomized trial examined tirzepatide in adults with obesity or overweight without diabetes.
Read the study note ↗